UK accounts for 12% of cell and gene therapy trials - report

The UK accounts for over 12% of global cell and gene therapy clinical trials, according to new data published by a government-backed agency.

MorphoSys gets $750m from Incyte for anti-CD19 cancer drug

Roche and Illumina forge genomics alliance for cancer testin...

Life with multiple myeloma

Multiple myeloma patient Bob Munro (pictured below) explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from

AI specialist Exscientia signs drug discovery tie-up with Ba...

China’s Adagene raises $69m for cancer immunotherapies